A - Human Necessities – 61 – K
Patent
A - Human Necessities
61
K
A61K 31/407 (2006.01) A61K 31/00 (2006.01) A61K 31/40 (2006.01)
Patent
CA 2323172
A method for treating renal dysfunctions is disclosed, particularly using the isozyme selective PKC inhibitor, (S)-3,4-[N,N'-1,1'-((2"-ethoxy)-3'''(O)-4'''- (N,N-dimethylamino)-butane)-bis-(3,3'-indoly1)]-1(H)-pyrrole-2,5- dionehydrochloridesalt.
Cette invention se rapporte à un procédé servant à traiter les dysfonctions rénales, utilisant notamment l'inhibiteur de PKC (protéine-kinase C) sélectif des isozymes, le sel hydrochlorure de (S)-3,4-[N,N'-1,1'-((2''-éthoxy)-3'''(O)-4'''-(N,N-diméthylamino)-butane-bis-(3,3'-indolyl)]-1(H)pyrrole-2,5-dione.
Gilbert Richard
Ways Douglas Kirk
Eli Lilly And Company
Gilbert Richard
Gowling Lafleur Henderson Llp
Ways Douglas Kirk
LandOfFree
Therapeutic treatment for renal dysfunction does not yet have a rating. At this time, there are no reviews or comments for this patent.
If you have personal experience with Therapeutic treatment for renal dysfunction, we encourage you to share that experience with our LandOfFree.com community. Your opinion is very important and Therapeutic treatment for renal dysfunction will most certainly appreciate the feedback.
Profile ID: LFCA-PAI-O-1425956